Home
       
STOCK MARKETS


Back

Corporate Information
  • Company Presentation
  • Business Segments
  • Strategy & Goals
  • President’s Message
  • Year in Brief
  • Management
  • Subsidiaries
  • Acquisitions & Divestments
  • Addresses
    News & Reports
  • Reports
  • Presentations
  • Press releases
    Financial Information
  • Financial Summary
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Illustrations
    Shareholder Information
  • Shareholders
  • Shares & Dividends
  • Annual General Meeting
  • Financial Calendar
     
       

    Embla Medical hf

    http://www.ossur.com
    Embla Medical hf
    Grjothals 5
    110 Reykjavik
    ICELAND
    Tel: ‎+ 354 515 1300
    Fax: ‎+ 354 515 1366
    E-mail: mail@ossur.com

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer
    Press releases  

    2011-05-04 20:18:52

    Össur - First Quarter Report 2011

    Össur - First Quarter Report 2011

    Announcement Össur hf. No. 06/2011
    Reykjavik, 4 May 2011

     

    EXCELLENT PERFORMANCE

     

    Sales -Sales growth was excellent, 11% measured in local currency. Total sales amounted to USD 97 million compared to USD 86 million in the first quarter of 2010. Performance in bracing and supports was excellent in Americas and moderate in EMEA. Overall sales growth of bracing and supports was 20%, measured in local currency. Sales growth in prosthetics was 5% measured in local currency.

     

    Profitability - Össur continues to deliver good profits and margins are stable.  EBITDA amounted to USD 18 million or 19% of sales and gross profit amounted to USD 61 million or 63% of sales. Net profit amounted to USD 8 million or 8% of sales.

     

    Jón Sigurðsson, President & CEO, comments:
    "The first quarter results are a good start of the year. We are pleased with the results and the overall performance is excellent. Strong contributors to the growth are some of the important products launched last year. Both main product segments show good growth and the bracing and supports segment in Americas is growing well above the market growth rate and we are gaining market share. We will continue to focus on strengthening our product offering and the product pipeline for 2011 contains some exciting products." 

     

    Highlights of the quarter: 

    • Excellent bracing and supports growth - In the first quarter of 2011 the bracing and supports segment in Americas delivered record growth and Össur is gaining share in the market. New products launched in 2010, such as Miami Lumbar and Rebound Walker, are amongst the best selling products and strong contributors to the growth in this segment.  
    • Mexico facility -Össur continues to build up its manufacturing facility for bracing and supports in Mexico.  In 2010 manufacturing of spinal products was moved from Allentown and Paulsboro and this year knee brace manufacturing is being moved from Foothill Ranch in California to Mexico.  
    • Financing -In March 2011 Össur signed an agreement with three international banks, ING Bank, Nordea and SEB, on long-term financing in the amount of USD 231 million. The financing is a milestone for Össur as the Company has now established international access to both debt and equity financing.

     

    Guidance 2011 - Management maintains estimates of LCY organic sales growth for 2011 in the range of 4-6%. EBITDA ratio adjusted is estimated to be in the range of 20-21% of sales for the year, as reported in the 2010 full year report.

     


     

    Conference call tomorrow 5 May at 12:00 CET/ 10:00 GMT/ 6:00 EDT

     

    Thursday 5 May 2011 Jón Sigurðsson, President and CEO, and Hjörleifur Pálsson, CFO, will host a conference call for investors, analysts and shareholders presenting and discussing the results of the first quarter of 2011. The conference call will be conducted in English and can be heard on Össur's website: www.ossur.com

     

    To participate in the meeting please call one of the following telephone numbers:
    Europe: +44 (0)20 3043 2436 or +46 (0)8 505 598 53
    The United States: +1 866 458 40 87
    Iceland: 800 8660




    This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

    The owner of this announcement warrants that:
    (i) the releases contained herein are protected by copyright and other applicable laws; and
    (ii) they are solely responsible for the content, accuracy and originality of the
    information contained therein.

    Source: Ossur Hf via Thomson Reuters ONE

    HUG#1512616



     
    Back
     
     
       Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024